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To investigate bluetongue virus serotype 8 infection 
in Belgium, we conducted a virologic and serologic survey 
on 2,416 free-ranging cervids during 2005–2008. Infection 
emerged in 2006 and spread over the study area in red 
deer, but not in roe deer.
B
luetongue virus serotype 8 (BTV-8) spread through-
out western Europe in 2006.  Belgium reported its ﬁ  rst 
case in farm ruminants in 2006. Because some cervid spe-
cies may be seriously affected by BTV and because they 
may be reservoir hosts (1), we conducted a large-scale sur-
vey of BTV-8 in Belgium.
The Study
Postmortem examinations were conducted on 1,620 red 
deer and 796 roe deer shot by hunters during hunting sea-
sons in 2005–2008 (online Technical Appendix, www.cdc.
gov/EID/content/16/5/833-Techapp.pdf). Sex, age, body 
condition, and macroscopic aspects of hooves, mucosae, 
and internal organs were recorded. Blood and spleen sam-
ples were obtained.
Antibodies against virus protein 7 were detected by 
using a competition ELISA kit (ID-VET, Montpellier, 
France). Results were expressed as percentage negativity 
compared with kit negative control serum, and cutoff val-
ues were established. Serum samples from 80 red deer and 
40 roe deer were also analyzed by using a virus neutral-
ization (VN) test for BTV-1 and BTV-8. Spleen samples 
obtained in 2006 and 2007 were used for detection of BTV 
RNA segment 5 and cellular β-actin transcripts by reverse 
transcription–quantitative PCR (RT-qPCR) according to a 
modiﬁ  ed procedure of Toussaint et al. (2).
To assess performance of the ELISA, we performed 
receiver operating characteristic analysis. To estimate ef-
fects of potential factors (sex and age, year, month and area 
of sampling) on risk for seropositivity, we used a multivari-
ate logistic regression model. Between-group differences 
were assessed by using the χ2 test.
A total of 237 pairs of ELISA and RT-qPCR results 
from red deer were used for receiver operating characteris-
tic analysis, which yielded an area under the curve of 0.811 
and a cutoff value for the ELISA that maximized sensitivity 
(86%) and speciﬁ  city (98%). Serologic status was deﬁ  ned 
as positive (<66%), doubtful (>66%–<75%), or negative 
(>75%) and was comparable to that found for domestic ru-
minants (3). For BTV-8, concordance between ELISA and 
VN results was 95% for red deer and 82% for roe deer. 
Neutralizing antibodies to BTV-1 were not detected.
From 2006 on, no gross lesions compatible with blu-
etongue disease were found. In 2005, all serum samples 
were negative. For hunting seasons in 2006, 2007, and 
2008, seroprevalences were 1.51% (95% conﬁ  dence in-
terval [CI] 0.89%–2.07%), 52.33% (95% CI 49.91%–
54.78%), and 33.95% (95% CI 31.64%–36.26%) for red 
deer and 2.56% (95% CI 1.43%–3.60%), 2.75% (95% CI 
1.62%–3.90%), and 1.67% (95% CI 0.75%–2.51%) for roe 
deer and showed a signiﬁ  cant difference between species 
(p<0.0001 by Cochran-Mantel test).
Yearly proﬁ   les of humoral immune responses are 
shown in Figure 1. Unimodal negatively skewed distri-
butions of percentage negativity in 2005 and 2006 likely 
reﬂ  ect seronegative populations. Conversely, bimodal pro-
ﬁ  les in 2007 and 2008 are compatible with ongoing infec-
tions in the red deer population. Spatial evolution of hu-
moral responses in red deer is shown in Figure 2. In 2006, 
seropositive animals were detected in only 5 districts, of 
which 4 were the most eastern districts among the 20 sam-
pled; deer in most districts were infected in 2007 (22/25) 
and 2008 (17/21).
In red deer, multiple logistic regression analysis showed 
that risk for seropositivity was signiﬁ  cantly affected by 
age (χ2 84.53, p<0.0001), year (χ2 282.75, p<0.0001), and 
location of sampling (χ2 63.10, p<0.0001), but not by sex 
(χ2 0.19, p>0.90) or month of sampling (χ2 2.45, p>0.45). 
Seroprevalence was lower for juveniles than for subadults 
(odds ratio 2.11, 95% CI 1.47–3.04) and adults (odds ratio 
3.79, 95% CI 2.85–4.62). The decrease in 2008 was sig-
niﬁ  cant only for juveniles, and the seropositivity gradient 
decreased toward southern part of the study region (Table). 
For roe deer, risk for seropositivity was not inﬂ  uenced by 
any factor.
The 343 spleen samples (230 red deer and 113 roe 
deer) tested by RT-qPCR in 2006 and the 193 samples 
(roe deer) tested in 2007 were negative for BTV RNA. 
Conversely, ≈14% (33/237) of red deer β-actin–positive 
samples (237/331) were positive for BTV RNA (online 
Technical Appendix). These 33 animals did not have gross 
lesions suggestive of bluetongue disease. Of 32 serum sam-
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5 were seronegative, which suggested that these animals 
had been infected recently. Two pan-BTV RNA–positive 
spleen fragments, sampled at the end of hunting season in 
2008, were reassessed by using a BTV-8 genotype–speciﬁ  c 
RT-qPCR (4); results were positive for all.
Conclusions
Our study provides evidence that BTV-8 infects wild 
cervid populations in Belgium. For red deer, a few infec-
tions occurred in 2006 in the eastern part of Belgium, i.e., 
the area in which the ovine and bovine cases had been 
detected (5). In 2007, the infection spread west and south-
west, and its seroprevalence increased. In 2008, distribu-
tion remained stable but overall seroprevalence decreased, 
mostly among juveniles. Distribution proﬁ  les of antibod-
ies against BTV in 2007 and 2008 showed a bimodal pro-
ﬁ  le. A large number of serum samples showed percentage 
negativity values between positive and negative values, 
which is indicative of ongoing virus transmission by vec-
tor midges during the hunting season. More animals were 
infected in eastern and central than in southern Wallonia, 
a ﬁ  nding that resembles the spatial distribution of the vi-
rus in livestock and might be correlated with lower den-
sity of cattle populations and cooler temperatures in hilly 
southern districts (6).
The proportion of seropositive animals increased with 
age, probably resulting more from prolonged exposure of 
adults to the vector, than to any resistant status of juveniles. 
Decreasing overall seroprevalence in 2008 might be caused 
by mandatory vaccination of domestic ruminants and spon-
taneously acquired herd immunity within the red deer popu-
lation, which reduced virus prevalence among insect vector 
populations in 2008. Because seropositive subadults and 
adults sampled in 2008 could have been infected in 2007, 
seroprevalence among juveniles should more accurately 
reﬂ  ect the level of exposure to infected insect vectors. If 
this explanation was true, the decrease in seroprevalence 
among juveniles in 2008 would conﬁ  rm reduction of the 
virus insect reservoir.
Although red deer and roe deer samples were collected 
at the same locations and during the same hunting events, 
seroprevalence was lower among roe deer. Because 5 of 
12 ELISA-positive and none of the ELISA-negative roe 
deer serum samples were positive by BTV-8 VN test and 
a similar between-species pattern was found by RT-qPCR, 
poor sensitivity of the ELISA in roe deer as the cause of 
between-species difference can be ruled out. Host-related 
and vector-related factors might account for this difference. 
Because red deer live in large groups and move more, they 
might be more exposed to insects/pathogens than are roe 
deer, which live in small groups in winter and have smaller 
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Figure 1. Frequency distribution of results of a competitive ELISA for detecting antibodies against bluetongue virus in serum samples from 
roe deer (white columns) and red deer (black columns) during the hunting seasons of A) 2005, B) 2006, C) 2007, and D) 2008, Belgium. 
Hunting was conducted in 30 (area 12,851 km2) of 37 (area 16,844 km2) forest districts known to contain wild cervids. The study population 
of wild cervids in southern Belgium (49°30′N–50°48′N) is estimated to be ≈11,000 red deer (Cervus elaphus) and ≈33,000 roe deer 
(Capreolus capreolus). Serum samples with a percentage negativity value (relative to the negative control serum) <66 were considered 
positive.Bluetongue Virus in Wild Deer, Belgium
home-range sizes and are seasonally territorial (7). More-
over, a recent follow-up of Culicoides spp. midge feeding 
patterns reported variations in host attractiveness, which 
could correlate with exhaled carbon dioxide and acetone 
(8), speciﬁ  c phenolic compounds emitted from urine (9) or 
hair fragrance (10).
BTV might be maintained in an as yet unknown reser-
voir host population with a long or relapsing viremia and in 
which clinical signs are absent. Because no excess illness 
or death occurred in 2007–2008, BTV-8 infection of wild 
cervids is probably benign enough to go unnoticed. Some 
spleen samples from dead red deer found during winter also 
showed positive results by RT-qPCR even if BTV was not 
the cause of death (A. Linden, unpub. data). Coupled with 
the high seroprevalence we report, the possibility that red 
deer are BTV reservoirs warrants further investigation.
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Figure 2. Distribution of red deer samples obtained in Belgium (Wallonia) in A) 2005, B) 2006, C) 2007, and D) 2008, and location of 
forest districts. White circles indicate districts where only seronegative animals were detected, and black circles indicate districts where 
seropositive animals were detected. Scale bar indicates 100 km.
Table. Seroprevalence of bluetongue virus among red deer, by age and study area, Belgium, 2006–2008* 
Characteristic
2006 2007  2008 
No. positive/ 
no. tested (%)  95% CI 
No. positive/ 
no. tested (%)  95% CI 
No. positive/ 
no. tested (%)  95% CI 
Age†
  Adults  4/221 (1.81)  0.05–3.57  142/216 (65.74)  59.41–72.07  111/185 (60.00)  52.94–67.06 
  Subadults  1/59 (1.69)  0.00–4.99  45/82 (54.88)  44.11–65.65  27/75 (36.00)  25.14–46.86 
  Juveniles  2/178 (1.12)  0.00–2.67  80/213 (37.56)  31.06–44.06  11/191 (5.76)  2.46–9.06 
Area‡ 
  Eastern  ND  ND  81/161 (50.31)  42.59–58.03  43/123 (34.96)  26.53–43.39 
  Central  ND  ND  103/154 (66.88)  59.45–74.32  61/135 (45.19)  36.79–53.58 
  Southern  ND  ND  32/105 (30.48)  21.67–39.28  27/133 (20.30)  13.46–27.14 
*CI, confidence interval; ND, not determined. 
†Adults, >2 y of age; subadults, 1–2 y of age; juveniles, <1 y of age. 
‡Fourteen forest districts were distributed among 3 nonadjacent areas, 5 in the eastern area, 4 in the central area, and 5 in the southern area. Dr Linden is a professor in the Department of Infectious and 
Parasitic Diseases in the Veterinary Faculty of the University of 
Liège. Her research interests focus on wildlife diseases.
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